Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction.

Chen, Yanjia; Qiu, Zeping; Jiang, Jie; Su, Xiuxiu; Huang, Fanyi; Tang, Jing; Jin, Wei

Chen, Yanjia; Qiu, Zeping; Jiang, Jie; Su, Xiuxiu; Huang, Fanyi; Tang, Jing; Jin, Wei.

Afiliación

Chen Y; Department of Vascular and Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qiu Z; Institute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiang J; Department of Vascular and Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Su X; Institute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huang F; Department of Emergency Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tang J; Department of Vascular and Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jin W; Department of Vascular and Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Front Cardiovasc Med ; 8: 725399, 2021.

Article en En | MEDLINE | ID: mdl-34604354

Palabras clave

dilated cardiomyopathy; heart failure management; heart failure with improved ejection fraction; spironolactone; withdrawal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies Idioma: En Revista: Front Cardiovasc Med Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google